A phase I/IIa safety, immunogenicity, and efficacy bridging randomized study of a two-dose regimen of liquid and lyophilized formulations of the candidate malaria vaccine RTS,S/AS02A in malaria-naïve adults
Titel:
A phase I/IIa safety, immunogenicity, and efficacy bridging randomized study of a two-dose regimen of liquid and lyophilized formulations of the candidate malaria vaccine RTS,S/AS02A in malaria-naïve adults
Auteur:
Kester, Kent E. McKinney, Denise A. Tornieporth, Nadia Ockenhouse, Christian F. Heppner Jr., D. Gray Hall, Ted Wellde, Bruce T. White, Kate Sun, Peifang Schwenk, Robert Krzych, Urszula Delchambre, Martine Voss, Gerald Dubois, Marie-Claude Gasser Jr., Robert A. Dowler, Megan G. O’Brien, Megan Wittes, Janet Wirtz, Robert Cohen, Joe Ballou, W. Ripley